Bringing together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers, OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies
throughout the drug development process. Attend in 2021 to optimize your drug design, delivery and performance, accelerate time to market and achieve commercial success. Based on the resounding success of last year’s
inaugural 2-day program dedicated to Oligonucleotide CMC & Regulatory Strategies we will once again be adding this content to complement our established Oligonucleotide Discovery and Delivery conference.
2021 VIRTUAL Programs
March 30-31, 2021
6th Annual Oligonucleotide Discovery and Delivery: Optimizing Design, Delivery and Performance
3rd Annual Oligonucleotide CMC and Regulatory Strategies: Accelerating Product Development and Commercial Success